Skip to main content
Equibles
RLMD $3.77 +1.07%
RLMD logo
RLMD · Relmada Therapeutics, Inc.
Track RLMD — free

Use RLMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RLMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.77 +0.04 (+1.07%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$408.55M
Shares
106.67M
Volume · Sep 30 999.53K Avg daily vol (3M) 1.36M
All earnings calls

Earnings call · FY2026 Q2

Relmada Therapeutics, Inc. (RLMD) Q2 2026 Earnings Call

Concluded Aug 6, 2026
Aug 6, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
3 artifacts
Slides 32 8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Diluted EPS -$0.11
Net income -$12.91M

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 32 slides 8-K earnings release Filed Aug 6, 2026 10-Q report Filed Aug 6, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks · derived
$6.46M
Full-screen source Call document

RLMD transcript alerts

Relmada Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →